Dr Richard Lee

Dr Richard Lee studied undergraduate medical sciences at Sidney Sussex College, University of Cambridge, and completed his medical training at Guy's, King's and St Thomas's medical school in 2005. He was awarded a PhD in lung cancer by Kings College London, which was funded by prestigious NIHR and MRC Clinical Research Training Fellowships and for which he received a British Thoracic Society Young Investigator award.

Dr Lee has a research interest in early diagnosis of all cancer types with a focus on lung cancer. He leads on biomarker development for the RM Partners Low-Dose CT Lung cancer case-finding study and the DART consortium/SCOOT study in collaboration with Oxford University. He has a research portfolio that includes translation of artificial intelligence research to early cancer detection and screening (LIBRA, OCTAPUS-AI and AI-SONAR studies) as well as alongside liquid biopsy research (NIMBLE study). Dr Lee also has an interest in using data science to improve lung cancer care and has previously developed a Smart-Phone app for respiratory trainees.

Dr Lee leads on Early Diagnosis strategy at The Royal Marsden, which is developing innovative clinical services to ensure that The Royal Marsden is an international thought-leader in early diagnosis and contributes actively to NHS England's 2028 ambition to diagnose 75% of all cancers at an early stage. Dr Lee is co-director of the RM and ICR Early Diagnosis and Detection Centre. His work in this area is funded by The Royal Marsden Cancer Charity with whom Dr Lee continues to work closely to promote the importance of early cancer diagnosis amongst patients, colleagues and the public.

Dr Lee is the Joint National Clinical Lead for the NHS England National Targeted Lung Health Check programme and NIHR National Speciality Lead for Screening, Prevention and Early Detection. He has previously served as the lung pathway chair at the Royal Marsden Partners Cancer Alliance, British Thoracic Society Lung Cancer Committee, and NIHR Health Informatics Collaborative for lung cancer. He is part of The European Respiratory Society's college of experts. He has also contributed to the development of Rapid Diagnosis Centres with NHS England and is CI for the RDC-BIO biomarker study.